LabCorp Begins Offering Exact Sciences’ PreGen-Plus Colorectal Cancer Test
This article was originally published in The Gray Sheet
Executive Summary
Exact Sciences hopes consultation with FDA on clinical utility trials for the firm's PreGen-Plus colorectal cancer screening assay will help fulfill potential regulatory requirements in the future